Self-Sampling for Human Papillomavirus (HPV) Testing in African American Women - Mississippi Delta

NCT03713710 — Not applicable, Completed, 335 participants, University of Alabama at Birmingham

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Self-Sampling for HPV Testing in African American Women - Mississippi Delta

RegistryNCT03713710, acronym HPV
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, screening
Enrollment335 (Actual)
SponsorUniversity of Alabama at Birmingham (Other); collaborators: American Cancer Society, Inc.
ConditionsCervical Cancer
InterventionsPap testing, Choice (Behavioral)
Datesstart 2016-11-28, primary completion 2019-12-31, completion 2019-12-31, first posted 2018-10-22, last updated 2022-11-16
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Cervical Cancer All trials of Pap testing All trials of Choice

-Summary

The purpose of this study is to examine the efficacy and costs of this patient-centered approach ("Choice" between two cervical cancer screening modalities) in adherence to cervical cancer screening as compared to the current standard of care within the public health system in Mississippi (Pap test at the local department -"Pap") among un/under-screened African American women in the Mississippi Delta using a theory-based, culturally relevant intervention implemented by Peer Health Educators (PHEs).

Expand all sections  ·  Collapse all

+Detailed description

OBJECTIVE: Our objective is to examine the efficacy and costs of a patient-centered approach ("Choice" between self-sampling and Pap test) in adherence to cervical cancer screening as compared to Pap test at the local health department ("Pap") among un/under-screened African American women in the Mississippi Delta.

HYPOTHESES: Women in the "Choice" arm will have a higher cervical cancer screening adherence as well as higher satisfaction than women assigned to the "Pap" arm; (2) Within the "Choice" arm, more women will choose and complete self-sampling than Pap test; and (3) The "Choice" intervention will be on average less costly and more cost-effective than the "Pap" intervention.

SPECIFIC AIMS: (1) To compare the impact of these two intervention approaches, "Choice" versus "Pap", on cervical cancer screening adherence through a group randomized controlled trial; (2) To compare patient satisfaction between the two intervention approaches; and (3) To compare the costs and cost-effectiveness of these two intervention approaches, "Choice" versus "Pap".

STUDY DESIGN: 12 towns will be randomized to either "Choice" or "Pap" (180 women/arm). Peer Health Educators (PHEs) will identify African American women who report not having undergone cervical cancer screening in the past three years and deliver a brief theory-based, cultural relevant educational session on cervical cancer and screening using a door-to-door approach. Women randomized to the "Pap" arm will be provided with information on how to schedule an appointment at the local health department. Women randomized to the "Choice" arm will be given the choice of attending the health department for a Pap test or self-collecting their own sample at home to be sent for HPV testing. PHEs will follow-up with women in either arm who have a positive test in order to assure diagnostic evaluation and care.

+Arms and interventions

ArmTypeInterventionsDescription
Pap testingExperimentalBehavioral: Pap testingWomen assigned to this arm will be scheduled a Pap testing appointment at the local health department
ChoiceExperimentalBehavioral: ChoiceWomen assigned to this arm will be given a choice between scheduling an appointment for a Pap testing at the health department or engage in self-sampling for HPV testing at home
  • Pap testing (Behavioral): Women will be approached in the community by a Peer Health Educator and scheduled an appointment for a Pap testing at the local health department
  • Choice (Behavioral): Women will be approached in the community by a Peer Health Educator and they will be given a choice between scheduling an appointment for a Pap testing at the local health department or engage in self-sampling for HPV testing at home

+Outcome measures

Primary outcomes

  • adherence to cervical cancer screening [baseline to 30 days]: adherence to cerivcal cancer screening by attending the Pap testing or returning the self-collected sample for HPV testing

Secondary outcomes

  • Satisfaction with the intervention [baseline to 6 months]: We will assess participants' satisfaction with intervention through self-report (satisfaction questionnaire - satisfied/very satisfied)

+Eligibility

Sex: Female, ages: 25 Years to 64 Years, accepts healthy volunteers

Inclusion Criteria:

* no personal history of cervical cancer
* not have engaged in cervical cancer screening in the past four years

Exclusion Criteria:

* none

+Locations (1)

FacilityCityCountryStatus
Mississippi State Department of HealthJackson, MississippiUnited States

+Publications

  • Results publication: Scarinci IC, Li Y, Tucker L, Campos NG, Kim JJ, Peral S, Castle PE. Given a choice between self-sampling at home for HPV testing and standard of care screening at the clinic, what do African American women choose? Findings from a group randomized controlled trial. Prev Med. 2021 Jan;142:106358. doi: 10.1016/j.ypmed.2020.106358. Epub 2020 Dec 16. PMID 33338505

+Investigators